BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38623031)

  • 1. Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic.
    Finsterer J; Mehri S
    Eur J Neurol; 2024 Jul; 31(7):e16307. PubMed ID: 38623031
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S.
    Mitsikostas DD; Caronna E; De Tommaso M; Deligianni CI; Ekizoglu E; Bolay H; Göbel CH; Kristoffersen ES; Lampl C; Moro E; Pozo-Rosich P; Sellner J; Terwindt G; Irimia-Sieira P
    Eur J Neurol; 2024 Jul; 31(7):e16308. PubMed ID: 38628031
    [No Abstract]   [Full Text] [Related]  

  • 3. Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review.
    Mitsikostas DD; Caronna E; De Tommaso M; Deligianni CI; Ekizoglu E; Bolay H; Göbel CH; Kristoffersen ES; Lampl C; Moro E; Pozo-Rosich P; Sellner J; Terwindt G; Irimia-Sieira P
    Eur J Neurol; 2024 Jun; 31(6):e16251. PubMed ID: 38415282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Questionnaire-based study of COVID-19 vaccination induced headache: evidence of clusters of adverse events.
    Zhou Q; Eggert T; Zhelyazkova A; Choukér A; Adorjan K; Straube A
    BMC Neurol; 2024 Mar; 24(1):84. PubMed ID: 38431578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study.
    Sekiguchi K; Watanabe N; Miyazaki N; Ishizuchi K; Iba C; Tagashira Y; Uno S; Shibata M; Hasegawa N; Takemura R; Nakahara J; Takizawa T
    Cephalalgia; 2022 Mar; 42(3):266-272. PubMed ID: 34407651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multisystem Inflammatory Syndrome in Children after SARS-CoV-2 Vaccination.
    Jain E; Donowitz JR; Aarons E; Marshall BC; Miller MP
    Emerg Infect Dis; 2022 May; 28(5):990-993. PubMed ID: 35275051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small fiber neuropathy underlying dysautonomia in COVID-19 and in post-SARS-CoV-2 vaccination and long-COVID syndromes.
    Finsterer J
    Muscle Nerve; 2022 Jun; 65(6):E31-E32. PubMed ID: 35385125
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 vaccinations in patients with chronic liver disease: Correspondence.
    Daungsupawong H; Wiwanitkit V
    J Gastrointestin Liver Dis; 2024 Jun; 33(2):281-282. PubMed ID: 38944866
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains.
    Poizeau F; Triquet L; Dupuy A
    Acta Derm Venereol; 2022 Jun; 102():adv00728. PubMed ID: 35506360
    [No Abstract]   [Full Text] [Related]  

  • 10. Sarcoidal immune reaction following SARS-CoV-2 vaccination.
    Abu Rached N; Mansour R; Susok L; Fried S; Abolmaali N; Lee YP; Gambichler T
    Clin Exp Dermatol; 2022 May; 47(5):970-972. PubMed ID: 34978352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accruing real-world data confirm that SARS-CoV-2 vaccination is not associated with stroke.
    Palaiodimou L
    J Neurol Sci; 2024 Jan; 456():120850. PubMed ID: 37923646
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute Thyroiditis and Bilateral Optic Neuritis following SARS-CoV-2 Vaccination with CoronaVac: A Case Report.
    Leber HM; Sant'Ana L; Konichi da Silva NR; Raio MC; Mazzeo TJMM; Endo CM; Nascimento H; de Souza CE
    Ocul Immunol Inflamm; 2021 Aug; 29(6):1200-1206. PubMed ID: 34402726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review.
    Afshar ZM; Barary M; Babazadeh A; Hosseinzadeh R; Alijanpour A; Miri SR; Sio TT; Sullman MJM; Carson-Chahhoud K; Langer F; Ebrahimpour S
    Rev Med Virol; 2022 Jul; 32(4):e2327. PubMed ID: 35112763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccination elicited
    Chen SP; Takizawa T; Sekiguchi K; Nakahara J; Wang SJ
    Cephalalgia; 2023 May; 43(5):3331024231173354. PubMed ID: 37138462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases with new onset of pemphigus foliaceus after SARS-CoV-2 vaccination.
    Rouatbi J; Aounallah A; Lahouel M; Sriha B; Belajouza C; Denguezli M
    Dermatol Ther; 2022 Nov; 35(11):e15827. PubMed ID: 36111460
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination.
    Hansbauer M; Fastantz E; Lutz J; Hasan A
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):502-503. PubMed ID: 35916561
    [No Abstract]   [Full Text] [Related]  

  • 17. Subacute thyroiditis after SARS-CoV-2 vaccination: report of two clinical cases.
    González López J; Martín Niño I; Arana Molina C
    Med Clin (Barc); 2022 Jun; 158(12):e13-e14. PubMed ID: 34893332
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous manifestations following SARS-CoV-2 vaccination.
    Majewska L
    Dermatol Ther; 2022 Nov; 35(11):e15784. PubMed ID: 36001633
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 Vaccination Associated Ophthalmic Adverse Effects.
    Serhan HA; Al-Shami KAA; Irshaidat S; Ullah I; Junaid Tahir M; Sohaib Asghar M; Yousaf Z
    Asia Pac J Ophthalmol (Phila); 2022 Nov; 11(6):566-567. PubMed ID: 35125422
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous T-Cell-Rich Lymphoid Infiltrates After SARS-CoV-2 Vaccination.
    Hooper MJ; Veon FL; LeWitt TM; Chung C; Choi J; Zhou XA; Guitart J
    JAMA Dermatol; 2022 Sep; 158(9):1073-1076. PubMed ID: 35857292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.